New Genome-Editing Strategy 'PERT' Offers Potential Treatment for Multiple Genetic Disorders Caused by Nonsense Mutations
Researchers have developed a new genome-editing approach called Prime-Editing-mediated Readthrough of premature Termination codons (PERT) to treat diseases caused by 'nonsense mutations.' These mutations create a premature 'stop' signal in DNA, halting protein production. PERT reprograms a cell's own genes to override these signals without disrupting global protein synthesis. Tested on models of Batten disease and Tay-Sachs, the method restored protein function significantly. This 'gene-agnostic' strategy could potentially treat thousands of rare diseases using a single platform, making therapy development faster and more cost-effective than creating separate treatments for each disorder.
Key Points
- Nonsense mutations account for about 25% of all known disease-causing genetic changes in humans.
- PERT uses 'suppressor tRNAs' to ignore premature stop signals and continue the assembly of full-length proteins.
- The strategy is 'gene-agnostic,' meaning the same tool can be adapted for different genes sharing the same mutation type.
- Successful laboratory tests were conducted on models of Batten disease, Tay-Sachs, and Niemann-Pick C1 disease.
Exam Facts
- Technology: Prime-Editing-mediated Readthrough of premature Termination codons (PERT).
- Mutation Type: Nonsense mutations (premature stop codons like TAG).
- Diseases Targeted: Cystic fibrosis, Batten disease, Tay-Sachs, Hurler syndrome.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.